Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Haemonetics (HAE) Receivables - Net (2016 - 2025)

Haemonetics has reported Receivables - Net over the past 16 years, most recently at $195.7 million for Q4 2025.

  • Quarterly results put Receivables - Net at $195.7 million for Q4 2025, down 7.66% from a year ago — trailing twelve months through Dec 2025 was $195.7 million (down 7.66% YoY), and the annual figure for FY2025 was $202.7 million, down 1.89%.
  • Receivables - Net for Q4 2025 was $195.7 million at Haemonetics, down from $207.1 million in the prior quarter.
  • Over the last five years, Receivables - Net for HAE hit a ceiling of $213.5 million in Q3 2024 and a floor of $127.6 million in Q2 2021.
  • Median Receivables - Net over the past 5 years was $180.1 million (2022), compared with a mean of $179.9 million.
  • Biggest five-year swings in Receivables - Net: fell 22.79% in 2021 and later grew 24.95% in 2022.
  • Haemonetics' Receivables - Net stood at $141.3 million in 2021, then rose by 28.16% to $181.1 million in 2022, then increased by 16.85% to $211.6 million in 2023, then grew by 0.16% to $211.9 million in 2024, then fell by 7.66% to $195.7 million in 2025.
  • The last three reported values for Receivables - Net were $195.7 million (Q4 2025), $207.1 million (Q3 2025), and $200.8 million (Q2 2025) per Business Quant data.